Additionally, the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and fibroblast growth factor 21 receptor (FG21R) also significantly influence these metabolic processes
On December 1, 2020, pralsetinib was approved for systemic therapy in advanced or metastatic RET mutation-positive MTC based on preliminary results of a phase 1/2 study (ARROW trial, NCT03037385)
Legro, MD, FACOG, can be reached at [email protected]
We spoke with Farhan Abdullah, DO, a board-certified internist and the medical director of Magnolia Functional Wellness, to learn about navigating Transportation Security Administration (TSA) screenings with GLP-1 medications, refrigeration requirements, and what to do if you miss a GLP-1 dose when youre traveling
Now, Arizona regulators are looking into complaints about ketamine misuse and improper distribution of prescription drugs
Its a question we get all the time, and the distinction is crucial
